| Gene symbol | IL13RA2 | Synonyms | CD213A2, CT19, IL-13R, IL13BP | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq23 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | interleukin 13 receptor subunit alpha 2 | ||||
| GTO ID | GTC0843 |
| Trial ID | ChiCTR2000028801 |
| Disease | Brain Glioma |
| Altered gene | IL13RA2 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | IL13Ra2 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Not Recruiting |
| Title | Phase I Clinical Study for the Safety and Efficacy of IL-13R alpha 2 CAR-T Cells in the Treatment of Advanced Glioma |
| Year | 2020 |
| Country | China |
| Company sponsor | The First Affiliated Hospital of Suzhou University |
| Cohort 1 | |||||||
|
|||||||